You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
The megabillion-dollar buyout of Life Technologies (NASDAQ: LIFE) by Thermo Fisher Scientific (TMO 5.97%) grabbed a lot of headlines earlier this week. Fool contributor Rich Smith, however, has a different story to tell.
It's the story of one overpriced company buying another company that's an even worse bargain, which resulted in a medical equipment behemoth that's even more egregiously overpriced than the two companies were separately.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Market-beating stocks from our award-winning service.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
